Faber Daeufer & Itrato proudly announces the promotion of Gina Wu to Counsel where she will be taking a project management and/or supervisory role in various large-scale transactional projects for clients. Wu’s recent accomplishments include supporting one of the firm’s international clients on R&D activities globally, which includes putting clinical trial agreements and service agreements in place to cover several investigational products and trials in various phases – ranging from a single U.S. site Phase 1 study to a Phase 3 multicenter study with over 120 sites globally. Her recent work also includes an increasing number of manufacturing and supply chain related agreements.
In addition to her work with clients, Wu serves on the firm’s Women’s Initiative Committee where she helps plan and organize committee activities and speakers. In connection with her role on the committee, she and a colleague will lead an upcoming firm-wide Pitch Project featuring at least three presentations focusing on marketing and business development.
Wu also served as a lead presenter in the firm’s client webinar on Clinical Trial Agreements During the COVID-19 Pandemic.
Faber is a dynamic, independent law firm that provides corporate and transactional counsel to clients in the life sciences industry and in other emerging technology sectors. Since its founding in 2003, the firm has built a premier boutique practice working with over 1,000 companies, research institutions and investors. The firm includes 24 lawyers, 8 contracts specialists, 1 corporate paralegal and 9 technology, finance and administration professionals. The firm is based in Waltham, Massachusetts and has offices in Oakland, New York and Philadelphia.